Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -59,802 | -35,070 | -16,334 | -6,849 | N/A |
| Depreciation Amortization | 4,284 | 1,857 | 313 | 34 | N/A |
| Accounts payable and accrued liabilities | 3,177 | 237 | 858 | 252 | N/A |
| Other Working Capital | 2,166 | -1,545 | 2,324 | 453 | N/A |
| Other Operating Activity | 5,541 | 3,321 | 335 | 285 | 0 |
| Operating Cash Flow | $-44,634 | $-31,200 | $-12,504 | $-5,825 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -120,998 | -47,352 | 0 | N/A | N/A |
| PPE Investments | -2,149 | -407 | -1,091 | -548 | N/A |
| Other Investing Activity | -293 | 25 | -100 | -376 | 0 |
| Investing Cash Flow | $-123,440 | $-47,734 | $-1,191 | $-924 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 100 | 2,450 | N/A |
| Common Stock Issued | 189,317 | 171 | 131 | N/A | N/A |
| Dividend Paid | -4,346 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 89,009 | 14,879 | 0 |
| Financing Cash Flow | $184,971 | $171 | $89,240 | $17,329 | $N/A |
| Beginning Cash Position | 7,427 | 86,190 | 10,645 | 65 | N/A |
| End Cash Position | 24,324 | 7,427 | 86,190 | 10,645 | N/A |
| Net Cash Flow | $16,897 | $-78,763 | $75,545 | $10,580 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,634 | -31,200 | -12,504 | -5,825 | N/A |
| Capital Expenditure | -2,149 | -407 | -1,091 | -548 | N/A |
| Free Cash Flow | -46,783 | -31,607 | -13,595 | -6,373 | 0 |